statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Key Events This Week: PCE, GDP, Fed Blackout And Earnings Gallore

 Hot on the heels of last week's tech and momentum rout, shaken traders will have to wait until Friday for the main...

Key Events This Week: PCE, GDP, Fed Blackout And Earnings Gallore

Amgen's Tezspire shows promising COPD trial results and potential market expansion beyond asthma. Comparison with Dupixent reveals significant benefits for eosinophil counts 150 cells/ L and 300...

Amgen/AstraZeneca's Asthma Drug Tezspire Vs. Sanofi/Regeneron's Blockbuster Dupixent - Analyst Gives His Pick

Discover results from Sanofi's Phase 2 study on frexalimab for relapsing multiple sclerosis. Explore sustained reduction in disease activity and lesion numbers with low relapse rates.
read more...

Sanofi's Multiple Sclerosis Antibody Shows Reduction Of Disease Activity

In this piece, we will take a look at the ten best weight loss drug stocks to buy now. If you want to skip our introduction to the rising weight loss drug industry and how it's one of the biggest...

10 Best Weight Loss Drug Stocks to Buy Now

Augustine Asset Management Inc. grew its holdings in shares of Sanofi (NASDAQ:SNY - Free Report) by 166.5% in the fourth quarter, according to the company in its most recent 13F filing with the...

Augustine Asset Management Inc. Raises Stock Holdings in Sanofi (NASDAQ:SNY)

Venturi Wealth Management LLC increased its position in Sanofi (NASDAQ:SNY - Free Report) by 163.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange...

Venturi Wealth Management LLC Purchases 332 Shares of Sanofi (NASDAQ:SNY)

Fulton Bank N.A. trimmed its stake in Sanofi (NASDAQ:SNY - Free Report) by 4.7% in the fourth quarter, HoldingsChannel.com reports. The fund owned 38,602 shares of the company's stock after selling...

Sanofi (NASDAQ:SNY) Shares Sold by Fulton Bank N.A.

Sanofi (EURONEXT: SAN and NASDAQ: SNY) has today announced the launch of Verorab (Sanofi Inactivated Rabies Vaccine) in the UK, an inactivated rabies vaccine indicated for pre-exposure and...

Sanofi Announces Launch of Verorab (Sanofi Inactivated Rabies Vaccine) in the UK for Pre-exposure and Post-exposure Prophylaxis of Rabies in All Age Groups

The drug, made by Sanofi, is a GLP-1 like Novo Nordisk's blockbuster diabetes injection Ozempic and weight loss counterpart Wegovy...

Diabetes drug similar to Ozempic helped slow progression of Parkinson's disease in small trial

Coastline Trust Co decreased its stake in shares of Sanofi (NASDAQ:SNY - Free Report) by 20.8% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund...

Coastline Trust Co Sells 2,450 Shares of Sanofi (NASDAQ:SNY)

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.

Volume	4.57M
52-Wk High	$56.26
52-Wk Low	$42.63

SNY Sanofi-Aventis

About

Feed

News

Sentiment

Fundamentals